• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算机对接鉴定的人丝氨酸蛋白酶抑制剂(SERPINs)的宿主细胞和病毒蛋白酶靶点。

Host cell and viral protease targets of human SERPINs identified by in silico docking.

作者信息

Rodriguez Galvan Joaquin, de Vries Maren, Belblidia Shiraz, Fisher Ashley, Prescott Rachel A, Crosse Keaton M, Hearing Patrick, Mangel Walter F, Duerr Ralf, Dittmann Meike

机构信息

New York University Grossman School of Medicine, Microbiology Department, New York, NY, USA.

New York University Grossman School of Medicine, Department of Medicine, New York, NY, USA.

出版信息

EMBO J. 2025 Sep 8. doi: 10.1038/s44318-025-00546-6.

DOI:10.1038/s44318-025-00546-6
PMID:40926121
Abstract

Serine protease inhibitors (SERPINs) are involved in various physiological processes and diseases, such as inflammation, cancer metastasis, and neurodegeneration. Their role in viral infections is poorly understood, as their expression patterns during infection and the range of proteases they target have yet to be fully characterized. Here, we show widespread expression of human SERPINs in response to respiratory virus infections, both in bronchioalveolar lavages from COVID-19 patients and in polarized human airway epithelial cultures. Using in silico docking of 10 SERPINs to 48 host proteases, we confirm known targets and predict new interactions. Protease activity assays validated selected interactions, confirming the newly predicted host targets for PAI-1 (SERPINE1) and PAI-2 (SERPINB2). PAI-1 inhibits cathepsin L, essential for SARS-CoV-2 maturation, and suppresses multi-cycle replication of both ancestral SARS-CoV-2 WA-1 and its variant Omicron BA.1. In addition, we identify PAI-2 as an antiviral SERPIN that reduces infectivity of human adenovirus 5 by directly inhibiting the adenoviral protease. Our study leverages in silico docking using full-length 3D protein structures to uncover new SERPIN targets, offering a range of candidate targets for therapeutic interventions.

摘要

丝氨酸蛋白酶抑制剂(SERPINs)参与多种生理过程和疾病,如炎症、癌症转移和神经退行性变。它们在病毒感染中的作用尚不清楚,因为它们在感染期间的表达模式以及所靶向的蛋白酶范围尚未完全明确。在此,我们发现人类SERPINs在应对呼吸道病毒感染时广泛表达,无论是在新冠肺炎患者的支气管肺泡灌洗液中,还是在极化的人气道上皮培养物中。通过对10种SERPINs与48种宿主蛋白酶进行计算机模拟对接,我们证实了已知靶点并预测了新的相互作用。蛋白酶活性测定验证了所选的相互作用,确认了PAI-1(SERPINE1)和PAI-2(SERPINB2)新预测的宿主靶点。PAI-1抑制组织蛋白酶L,这对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的成熟至关重要,并抑制原始SARS-CoV-2 WA-1及其变体奥密克戎BA.1的多轮复制。此外,我们确定PAI-2是一种抗病毒SERPIN,它通过直接抑制腺病毒蛋白酶来降低人腺病毒5的感染性。我们的研究利用全长3D蛋白质结构的计算机模拟对接来发现新的SERPIN靶点,为治疗干预提供了一系列候选靶点。

相似文献

1
Host cell and viral protease targets of human SERPINs identified by in silico docking.通过计算机对接鉴定的人丝氨酸蛋白酶抑制剂(SERPINs)的宿主细胞和病毒蛋白酶靶点。
EMBO J. 2025 Sep 8. doi: 10.1038/s44318-025-00546-6.
2
docking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2.具有丝氨酸蛋白酶抑制剂(SERPIN)结构的对接平台确定了对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)具有重要意义的宿主半胱氨酸蛋白酶靶点。
bioRxiv. 2024 Mar 27:2022.11.18.517133. doi: 10.1101/2022.11.18.517133.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Antiviral efficacy of hexane extract of Hypericum gaitii Haines against Chikungunya and SARS-CoV-2 viruses: in vitro and in silico approaches.盖氏金丝桃己烷提取物对基孔肯雅病毒和新型冠状病毒2的抗病毒效力:体外和计算机模拟方法
J Ethnopharmacol. 2025 Jul 10;353(Pt A):120270. doi: 10.1016/j.jep.2025.120270.
5
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式,并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
8
DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication.DAZAP2通过抑制病毒进入和基因组复制,作为一种泛冠状病毒限制因子发挥作用。
mBio. 2025 Aug 20:e0038525. doi: 10.1128/mbio.00385-25.
9
Adenovirus Remodeling of the Host Proteome and Host Factors Associated with Viral Genomes.腺病毒对宿主蛋白质组的重塑以及与病毒基因组相关的宿主因子
mSystems. 2021 Aug 31:e0046821. doi: 10.1128/mSystems.00468-21.
10
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

本文引用的文献

1
The HADDOCK2.4 web server for integrative modeling of biomolecular complexes.HADDOCK2.4 网页服务器用于生物分子复合物的整合建模。
Nat Protoc. 2024 Nov;19(11):3219-3241. doi: 10.1038/s41596-024-01011-0. Epub 2024 Jun 17.
2
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.重组 C1 抑制剂预防重症 COVID-19:一项随机、开放标签、多中心 IIa 期临床试验。
Front Immunol. 2023 Oct 27;14:1255292. doi: 10.3389/fimmu.2023.1255292. eCollection 2023.
3
Serpin-1a and serpin-6 regulate the Toll pathway immune homeostasis by synergistically inhibiting the Spätzle-processing enzyme CLIP2 in silkworm, Bombyx mori.
丝氨酸蛋白酶抑制剂 1a 和 6 通过协同抑制鳞翅目昆虫家蚕中的 Spätzle 加工酶 CLIP2 来调节 Toll 通路免疫稳态。
PLoS Pathog. 2023 Oct 18;19(10):e1011740. doi: 10.1371/journal.ppat.1011740. eCollection 2023 Oct.
4
The under-appreciated world of the serpin family of serine proteinase inhibitors.丝氨酸蛋白酶抑制剂家族——被低估的世界。
EMBO Mol Med. 2023 Jun 7;15(6):e17144. doi: 10.15252/emmm.202217144. Epub 2023 May 9.
5
"Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.“超级”丝氨酸蛋白酶抑制剂——血栓炎症状态下对抗纤维蛋白溶解的稳定力量。
Front Cardiovasc Med. 2023 Apr 19;10:1146833. doi: 10.3389/fcvm.2023.1146833. eCollection 2023.
6
The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine.腺病毒载体平台:对合理载体设计的新见解和从 COVID-19 疫苗中吸取的经验教训。
Viruses. 2023 Jan 11;15(1):204. doi: 10.3390/v15010204.
7
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis.奈玛特韦/利托那韦(Paxlovid)治疗 COVID-19 的疗效和安全性:快速评价和荟萃分析。
J Med Virol. 2023 Feb;95(2):e28441. doi: 10.1002/jmv.28441.
8
The Key Role of Lysosomal Protease Cathepsins in Viral Infections.溶酶体蛋白酶组织蛋白酶在病毒感染中的关键作用。
Int J Mol Sci. 2022 Aug 13;23(16):9089. doi: 10.3390/ijms23169089.
9
Spatial localization of cathepsins: Implications in immune activation and resolution during infections.组织蛋白酶的空间定位:在感染期间免疫激活和免疫应答中的意义。
Front Immunol. 2022 Aug 3;13:955407. doi: 10.3389/fimmu.2022.955407. eCollection 2022.
10
QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.furin 切割位点上游的 QTQTN 基序在 SARS-CoV-2 感染和发病机制中起关键作用。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2205690119. doi: 10.1073/pnas.2205690119. Epub 2022 Jul 26.